– New manufacturing plant and quality centre to create huge job opportunities for Telangana’s youth
– This is one of the largest Pharma investments in recent years
– Eli Lilly’s trust in Telangana goes beyond GCCs and towards new medicines to treat diabetes, cancer, Alzheimer’s
– Chief Minister A. Revanth Reddy had inaugurated the Eli Lilly GCC in Hyderabad on August 4
– Manufacturing and quality control facilities worth $1 billion to open new avenues for Telangana’s growth as a global Life Sciences hub
– Eli Lilly to manufacture in Telangana, and supply globally
HYDERABAD, OCTOBER 06, 2025: Telangana secured a massive investment of $1 billion by US Pharma major Eli Lilly, which will expand its manufacturing and global medicine supply capacity in Hyderabad. A new manufacturing plant and quality centre will be set up, creating huge job opportunities for Telangana’s youth.
The announcement was made after the company’s global delegation met Chief Minister A Revanth Reddy and Industries Minister D. Sridhar Babu at the Integrated Command Control Centre on Monday.
The investment decision reiterates the company’s trust in Telangana’s leadership and effective governance, after having inaugurated the global capability centre in Hyderabad in August this year. Despite strong interest from several states, Eli Lilly chose Telangana owing to the favourable ecosystem in terms of availability of highly skilled manpower, infrastructure, and support from the government.
The $1 billion investment by Eli Lilly marks the company’s interest in Telangana beyond GCCs and addressing new medicines to treat diabetes and obesity, Alzheimer’s disease, cancer and autoimmune conditions. The company will begin recruitment immediately for the Hyderabad location, with openings across roles such as engineers, chemists, analytical scientists, quality control and assurance professionals, and management positions.
With the setup of the new facilities, Eli Lilly is set to manufacture in Telangana, and supply globally.
The Chief Minister thanked the Eli Lilly delegation for having chosen Telangana and assured them of full support from the government for the company’s future expansion plans. He attributed the origin of Hyderabad as a Pharma hub to the then Prime Minister Indira Gandhi establishing the IDPL in Hyderabad in 1965.
“Indira Gandhi’s initiative in 1965 is the reason why Hyderabad stands as a hub of bulk drug manufacturing. Hyderabad was also at the epicentre of the Covid vaccine manufacturing at the global stage.”
The Chief Minister further reiterated, “Telangana means business. Hyderabad is a global city. Our government will support and welcome all industries looking to invest here.”
He also explained about the government’s plans to transform Telangana into a knowledge hub, adding that a new Advanced Technology Centre (ATC) is being setup at Hyderabad’s Genome Valley to ensure technical support for the companies. We have included several renowned Pharma industrialists to the Board of Governors of the Young India Skills University in Hyderabad, for which Anand Mahindra is the chairperson, he added.
On this occasion, Minister Sridhar Babu said Lilly’s expansion in Hyderabad is a testament to Telangana’s dynamic industrial landscape and its growing influence in advanced healthcare manufacturing.
Patrik Jonsson, Executive Vice President and President Lilly International, Eli Lilly, emphasised that this investment reaffirms the company’s confidence in India as a hub for capability building within our global network.
About the Author
